Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Vertex Pharmaceuticals (NQ:VRTX)

464.81 -5.71 (-1.21%)
Streaming Delayed Price Updated: 1:54 PM EST, Feb 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Research
Quarterly Reports Insider Filings Other Filings

All News about Vertex Pharmaceuticals

< Previous 1 2
...
26 27 28 29 30 31 32 33 34
...
70 71 Next >
News headline image
Momentum Shifts Back To Tech Stocks As Healthcare Lags In 2024 ↗
Small Cap traders are taking a break in 2024 as XBI is down 2.51% YTD. 
Via Talk Markets
News headline image
A New S&P 500 Bull Market Just Began: 3 No-Brainer Stocks to Buy Hand Over Fist ↗
These stocks seem likely to keep up their winning ways. 
Via The Motley Fool
Topics Stocks
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
Here's How Much $1000 Invested In Vertex Pharmaceuticals 10 Years Ago Would Be Worth Today ↗
 
Via Benzinga
News headline image
If You Invested $10,000 in Vertex Pharmaceuticals in 2018, This Is How Much You Would Have Today ↗
Has investing in Vertex been a better option than just putting your money in the S&P 500? 
Via The Motley Fool
Topics Stocks
News headline image
Market Whales and Their Recent Bets on VRTX Options ↗
 
Via Benzinga
News headline image
The Best Stock to Invest $1,000 in Right Now ↗
This stock has what it takes to be a big winner. 
Via The Motley Fool
News headline image
Unpacking the Latest Options Trading Trends in Vertex Pharmaceuticals ↗
 
Via Benzinga
News headline image
Cathie Wood's Flagship ARKK ETF Is Taking On Water Due To Coinbase, Tesla, These Stocks ↗
The flagship ETF's top holdings are down in 2024, especially No. 1 Coinbase. 
Via Investor's Business Daily
Topics ETFs
News headline image
2 Smart Growth Stocks to Buy Hand Over Fist in 2024 ↗
These businesses are on paths to extremely bright futures. 
Via The Motley Fool
News headline image
3 Unstoppable Growth Stocks That Can Make You Richer in 2024 ↗
These big winners of 2023 could keep their momentum going in the new year. 
Via The Motley Fool
News headline image
These 2 Phenomenal Growth Stocks Can Make You Richer in 2024 ↗
One market-beating stock and one beaten-down stock look like tempting buys for very different reasons. 
Via The Motley Fool
News headline image
3 High-Flying Stocks That Could Soar Even More in 2024 ↗
These big winners could keep the momentum going. 
Via The Motley Fool
News headline image
Vertex to Announce Fourth Quarter and Full Year 2023 Financial Results on February 5
From Vertex Pharmaceuticals Incorporated
Via Business Wire
News headline image
Gene Therapy For Beta-Thalassemia: CRISPR Therapeutics/Vertex's Casgevy Secures FDA Nod Ahead of Schedule ↗
FDA approves CRISPR Therapeutics/Vertex's Casgevy a gene-edited cell therapy for transfusion-dependent beta-thalassemia. Vertex's swift launch strategy targets a network of treatment centers across the... 
Via Benzinga
News headline image
Crispr Wins Its Second Gene-Editing Approval In Another Boost To Vertex Stock ↗
Shares of Vertex have risen exponentially since last month. Crispr stock, though, is meandering. 
Via Investor's Business Daily
News headline image
Vertex Announces US FDA Approval of CASGEVY™ (exagamglogene autotemcel) for the Treatment of Transfusion-Dependent Beta Thalassemia
From Vertex Pharmaceuticals Incorporated
Via Business Wire
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
Here's Why CRISPR Therapeutics Stock Rose 54% Last Year ↗
Key regulatory developments sent this biotech stock higher. 
Via The Motley Fool
News headline image
Down 88%, Could Editas Medicine Be a Good Investment Now? ↗
The past few years have been difficult ones, but shares of the gene editor are far more attractive now that a CRISPR medicine has passed regulatory hurdles. 
Via The Motley Fool
News headline image
My 3 Highest-Conviction Growth Stocks to Buy in 2024 ↗
Simply put, these stocks inspire confidence. 
Via The Motley Fool
News headline image
3 Growth Stocks to Buy That Could Be Massive Long-Term Winners ↗
These stocks appear to have what it takes to keep up their winning ways. 
Via The Motley Fool
News headline image
3 Unstoppable Stocks to Buy in 2024 ↗
These stocks appear to be on a clear path to continued growth. 
Via The Motley Fool
News headline image
Cathie Wood Goes Bargain Hunting: 3 Stocks She Bought This Week ↗
These companies could stand out thanks to game-changing technology. 
Via The Motley Fool
News headline image
Uber, Abbott Laboratories, Vertex Pharmaceuticals And More On CNBC's 'Final Trades' ↗
On CNBC’s "Halftime Report Final Trades," Joshua Brown of Ritholtz Wealth Management said Uber Technologies, Inc. (NYSE: UBER) shares hit an all-time high on Thursda 
Via Benzinga
News headline image
3 Stocks to Buy in the Booming Field of Gene Editing ↗
As the promise of gene editing moves closer to being a reality, these gene editing stocks have the opportunity for long-term gains. 
Via InvestorPlace
News headline image
Should Quality-Oriented Investors Explore VERTEX PHARMACEUTICALS INC (NASDAQ:VRTX)? ↗
Reasonable growth and debt and a high ROIC for VERTEX PHARMACEUTICALS INC (NASDAQ:VRTX). 
Via Chartmill
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
2 Red Flags for Bluebird Bio Stock ↗
The biotech's struggles may continue. 
Via The Motley Fool
News headline image
These 3 Stocks Have Beaten the S&P Average Return for Years and Are Likely to Continue That Trend ↗
These winners seem likely to keep up their winning ways. 
Via The Motley Fool
Topics Stocks
< Previous 1 2
...
26 27 28 29 30 31 32 33 34
...
70 71 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.